HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Nicolas Frances Selected Research
Nicolas Frances Research Topics
Disease
6
Neoplasms (Cancer)
11/2023 - 01/2012
3
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2023 - 12/2017
1
Disease Progression
01/2022
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2022
1
Melanoma (Melanoma, Malignant)
01/2022
1
Peripheral Nervous System Diseases (PNS Diseases)
12/2020
1
Spinal Muscular Atrophy (Progressive Muscular Atrophy)
01/2019
1
Breast Neoplasms (Breast Cancer)
01/2012
1
Neutropenia
01/2011
1
Head and Neck Neoplasms (Head and Neck Cancer)
01/2011
1
Sepsis (Septicemia)
01/2011
1
Dihydropyrimidine Dehydrogenase Deficiency
01/2011
1
Diarrhea
05/2009
1
Fever (Fevers)
05/2009
Drug/Important Bio-Agent (IBA)
3
Capecitabine (Xeloda)
FDA Link
01/2012 - 05/2009
2
Biomarkers (Surrogate Marker)
IBA
11/2023 - 12/2016
2
Paclitaxel (Taxol)
FDA Link
Generic
11/2023 - 12/2020
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
12/2017 - 12/2016
2
Gefitinib (Iressa)
FDA Link
12/2017 - 12/2016
1
Platinum
IBA
11/2023
1
glofitamab
IBA
01/2022
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
01/2022
1
cibisatamab
IBA
01/2021
1
Bispecific Antibodies
IBA
01/2021
1
Antigens
IBA
01/2021
1
Neoplasm Antigens (Tumor Antigens)
IBA
01/2021
1
Risdiplam
IBA
01/2019
1
Messenger RNA (mRNA)
IBA
01/2019
1
ErbB Receptors (EGF Receptor)
IBA
12/2017
1
Tyrosine Kinase Inhibitors
IBA
12/2017
1
Docetaxel (Taxotere)
FDA Link
01/2012
1
Fluorouracil (Carac)
FDA Link
Generic
01/2011
Therapy/Procedure
2
Drug Therapy (Chemotherapy)
11/2023 - 01/2011
1
Therapeutics
01/2022
1
Immunotherapy
01/2021
1
Aftercare (After-Treatment)
12/2017
1
Chemoradiotherapy
01/2011